Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-26

Clinical Trial Update: Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel [Phase 4]

View source ↗

Summary

This Phase 4 update reports completion and results posting for a trial evaluating Aczone 5% Gel as maintenance therapy for acne vulgaris after doxycycline treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aczone 5% Gel (dapsone topical)

Snippet

Sponsor: Derm Research, PLLC | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2015-02-26